Atyr Pharma Inc (ATYR)

09:49 AM

Why hedge funds are buying aTyr Pharma Inc. stock2025 EndofYear Setup & Risk Managed Investment Entry Signals - mfd.ru

09:49 AM

Feb 13, 2026

Why analysts upgrade aTyr Pharma Inc. stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - mfd.ru

Feb 13, 2026

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics - Barchart.com

Feb 13, 2026

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth - openPR.com

Feb 13, 2026

Feb 13, 2026

Is aTyr Pharma Inc. stock resilient to inflationJuly 2025 Market Mood & High Accuracy Trade Alerts - mfd.ru

Feb 13, 2026

Feb 06, 2026

Weekly Buzz: ATYR To Meet With FDA, SGMO Aces Fabry Study, AQST's Anaphylm Gets Rejected - RTTNews

Feb 06, 2026

Feb 06, 2026

Aug Summary: Does aTyr Pharma Inc have pricing powerJuly 2025 Reactions & Community Consensus Trade Signals - baoquankhu1.vn

Feb 06, 2026

Feb 05, 2026

Market Outlook: Does aTyr Pharma Inc have pricing powerJuly 2025 Pullbacks & High Conviction Investment Ideas - baoquankhu1.vn

Feb 05, 2026

Feb 05, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: aTyr Pharma (ATYR), Pfizer (PFE) and Bicycle Therapeutics (BCYC) - The Globe and Mail

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CEO Shukla sells $3.6k in stock - Investing.com

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CEO Shukla sells $3.6k in stock By Investing.com - Investing.com Nigeria

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CFO Broadfoot sells $1.5k in stock By Investing.com - Investing.com South Africa

Feb 05, 2026

Feb 05, 2026

Atyr Pharma CFO Broadfoot sells $1.5k in stock - Investing.com

Feb 05, 2026

Feb 04, 2026

aTyr Pharma general counsel sells $1091 in stock By Investing.com - Investing.com UK

Feb 04, 2026

Feb 04, 2026

aTyr Pharma general counsel sells $1091 in stock - Investing.com

Feb 04, 2026

Feb 03, 2026

FDA to review aTyr Pharma’s efzofitimod data in mid-April meeting - Investing.com Nigeria

Feb 03, 2026

Feb 03, 2026

aTyr Pharma gets FDA meeting on lead drug (ATYR:NASDAQ) - Seeking Alpha

Feb 03, 2026

Feb 03, 2026

Atyr Pharma announces scheduling of FDA type C meeting to discuss efzofitimod program in pulmonary sarcoidosis - marketscreener.com

Feb 03, 2026

Feb 03, 2026

aTyr Pharma (ATYR) Prepares for Key FDA Meeting on Efzofitimod - GuruFocus

Feb 03, 2026

Feb 03, 2026

aTyr Pharma Schedules FDA Meeting to Discuss Phase 3 EFZO-FIT™ Study Results for Efzofitimod in Pulmonary Sarcoidosis - Quiver Quantitative

Feb 03, 2026

Feb 03, 2026

ATyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis - marketscreener.com

Feb 03, 2026

Feb 03, 2026

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis - GlobeNewswire

Feb 03, 2026

Feb 03, 2026

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Feb 03, 2026

Feb 02, 2026

Federated Hermes Inc. Sells 4,122,163 Shares of aTyr Pharma, Inc. $ATYR - MarketBeat

Feb 02, 2026

Feb 02, 2026

Short Interest in aTyr Pharma, Inc. (NASDAQ:ATYR) Drops By 14.7% - MarketBeat

Feb 02, 2026

Jan 30, 2026

Aug Action: What is aTyr Pharma Inc.’s TAM (Total Addressable Market)2025 Dividend Review & Free Reliable Trade Execution Plans - baoquankhu1.vn

Jan 30, 2026

Jan 29, 2026

Is aTyr Pharma Inc. stock forming a triangle patternJuly 2025 Catalysts & Safe Capital Preservation Plans - Mfd.ru

Jan 29, 2026

Jan 21, 2026

Is aTyr Pharma Inc backed by strong institutional buyingJuly 2025 WrapUp & Reliable Intraday Trade Plans - baoquankhu1.vn

Jan 21, 2026

Jan 20, 2026

Aug Update: Does aTyr Pharma Inc. have pricing powerMarket Risk Analysis & Fast Gain Swing Alerts - baoquankhu1.vn

Jan 20, 2026

Jan 19, 2026

aTyr Pharma, Inc. (NASDAQ:ATYR) Sees Significant Drop in Short Interest - MarketBeat

Jan 19, 2026

Jan 17, 2026

Published on: 2026-01-18 01:23:30 - baoquankhu1.vn

Jan 17, 2026

Jan 14, 2026

Volume Recap: What drives aTyr Pharma Incs stock priceWeekly Stock Recap & AI Powered Market Trend Analysis - baoquankhu1.vn

Jan 14, 2026

Jan 11, 2026

Is aTyr Pharma (NASDAQ:ATYR) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Jan 11, 2026

Jan 09, 2026

aTyr Pharma, Inc. (NASDAQ:ATYR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Jan 09, 2026

Jan 08, 2026

How aTyr Pharma Inc. stock benefits from tech adoptionMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Will aTyr Pharma Inc. stock outperform growth indexesTrade Entry Report & Free Technical Confirmation Trade Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Will aTyr Pharma Inc. stock split attract more investorsJuly 2025 Summary & Long-Term Growth Plans - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Aug Chart Watch: How aTyr Pharma Inc. stock benefits from tech adoptionWeekly Stock Recap & Intraday High Probability Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Can aTyr Pharma Inc. (471A) stock sustain breakout momentumDay Trade & Safe Capital Allocation Plans - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Aug EndMonth: Will aTyr Pharma Inc. stock split attract more investorsJuly 2025 WrapUp & Risk Adjusted Buy/Sell Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

How strong is aTyr Pharma Inc. stock revenue growthPortfolio Return Report & Low Risk Investment Opportunities - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

aTyr Pharma, Inc. (ATYR) Stock Analysis: Unveiling a 483% Potential Upside in Biotech Innovation - DirectorsTalk Interviews

Jan 08, 2026

Jan 08, 2026

aTyr Pharma (NASDAQ:ATYR) Stock Price Up 3.1%Still a Buy? - MarketBeat

Jan 08, 2026

Jan 07, 2026

Will aTyr Pharma Inc. stock attract ESG investorsStock Watchlist Updates & Exceptional Trading Strategies - ulpravda.ru

Jan 07, 2026